Literature DB >> 18346720

The chemical structure and genetic locus of Campylobacter jejuni CG8486 (serotype HS:4) capsular polysaccharide: the identification of 6-deoxy-D-ido-heptopyranose.

Yu-Han Chen1, Frédéric Poly, Zbigniew Pakulski, Patricia Guerry, Mario A Monteiro.   

Abstract

In line with our on-going efforts to create a multivalent anti-Campylobacter jejuni vaccine based on its capsule polysaccharides (CPSs), we report here the chemical structure and the genetic locus of the CPS produced by C. jejuni strain CG8486, which belongs to the serotype HS:4 CPS complex. C. jejuni CG8486 CPS was observed to be composed of approximately 17 disaccharide repeating blocks of 4-substituted N-acetyl-beta-D-glucopyranosamine and 3-substituted 6-deoxy-beta-D-ido-heptopyranose. A small number of 6-deoxy-beta-D-ido-heptopyranose units were observed to carry O-methyl phosphoramidate moieties at the O-2 or O-7 position. The gene content and organization of the CPS locus of C. jejuni CG8486 were comparable to those of C. jejuni strains NCTC 11168 and 81-176, but several CG8486 CPS genes were observed to be more divergent from those present in the CPS loci of NCTC 11168 and 81-176 CPS, which indicated that there are genetic characteristics specific to the C. jejuni HS:4 CPS complex. The efficacy of a glycoconjugate vaccine based on C. jejuni CG8486 CPS is presently being tested in an animal model, the results of which will be presented in future communications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18346720     DOI: 10.1016/j.carres.2008.02.024

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  12 in total

1.  Discrimination of major capsular types of Campylobacter jejuni by multiplex PCR.

Authors:  Frédéric Poly; Oralak Serichatalergs; Marc Schulman; Jennifer Ju; Cory N Cates; Margaret Kanipes; Carl Mason; Patricia Guerry
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

2.  Complete 6-deoxy-D-altro-heptose biosynthesis pathway from Campylobacter jejuni: more complex than anticipated.

Authors:  Matthew McCallum; Steven D Shaw; Gary S Shaw; Carole Creuzenet
Journal:  J Biol Chem       Date:  2012-07-11       Impact factor: 5.157

3.  Capsule polysaccharide conjugate vaccine against diarrheal disease caused by Campylobacter jejuni.

Authors:  Mario A Monteiro; Shahida Baqar; Eric R Hall; Yu-Han Chen; Chad K Porter; David E Bentzel; Lisa Applebee; Patricia Guerry
Journal:  Infect Immun       Date:  2008-12-29       Impact factor: 3.441

4.  The Campylobacter jejuni NCTC11168 capsule prevents excessive cytokine production by dendritic cells.

Authors:  Anna Rose; Emily Kay; Brendan W Wren; Margaret J Dallman
Journal:  Med Microbiol Immunol       Date:  2011-08-24       Impact factor: 3.402

5.  Primary isolation strain determines both phage type and receptors recognised by Campylobacter jejuni bacteriophages.

Authors:  Martine C Holst Sørensen; Yilmaz Emre Gencay; Tina Birk; Signe Berg Baldvinsson; Claudia Jäckel; Jens A Hammerl; Christina S Vegge; Horst Neve; Lone Brøndsted
Journal:  PLoS One       Date:  2015-01-13       Impact factor: 3.240

6.  Genetic Characteristics and Multiple-PCR Development for Capsular Identification of Specific Serotypes of Campylobacter jejuni.

Authors:  Hao Liang; Aiyu Zhang; Yixin Gu; Yuanhai You; Jianzhong Zhang; Maojun Zhang
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

7.  Comparison of genomes and proteomes of four whole genome-sequenced Campylobacter jejuni from different phylogenetic backgrounds.

Authors:  Clifford G Clark; Chih-Yu Chen; Chrystal Berry; Matthew Walker; Stuart J McCorrister; Patrick M Chong; Garrett R Westmacott
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

8.  Phase variable expression of capsular polysaccharide modifications allows Campylobacter jejuni to avoid bacteriophage infection in chickens.

Authors:  Martine C Holst Sørensen; Lieke B van Alphen; Christopher Fodor; Shauna M Crowley; Bjarke Bak Christensen; Christine M Szymanski; Lone Brøndsted
Journal:  Front Cell Infect Microbiol       Date:  2012-02-20       Impact factor: 5.293

Review 9.  Campylobacter polysaccharide capsules: virulence and vaccines.

Authors:  Patricia Guerry; Frédéric Poly; Mark Riddle; Alexander C Maue; Yu-Han Chen; Mario A Monteiro
Journal:  Front Cell Infect Microbiol       Date:  2012-02-15       Impact factor: 5.293

10.  Updated Campylobacter jejuni Capsule PCR Multiplex Typing System and Its Application to Clinical Isolates from South and Southeast Asia.

Authors:  Frédéric Poly; Oralak Serichantalergs; Janelle Kuroiwa; Piyarat Pootong; Carl Mason; Patricia Guerry; Craig T Parker
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.